Study: Transfusion decisions vary widely in surgery | Silicone "trap" could reduce blood volume needed for tests | Microfluidic device extracts cancer cells from blood samples
Web Version
 
 
April 26, 2012
AABB SmartBrief
News for the transfusion medicine and cellular therapy community
SIGN UP|FORWARD|ARCHIVE

Top StorySponsored By
Study: Transfusion decisions vary widely in surgery
Doctors' decisions on when to transfuse can vary widely, and the association between transfusion and patient outcomes is inconsistent, according to a Johns Hopkins University study published in the journal Anesthesiology. Researchers evaluated the records of more than 48,000 patients, almost 3,000 of whom received blood transfusions during surgery, and found notable differences in hemoglobin levels at the time of transfusion. Doctors should be more aware of transfusion guidelines, and more education is needed, researchers said. Read about the AABB clinical practice guideline on red cell transfusion here. The Sun (Baltimore)/Picture of Health blog (4/25)
Share: LinkedInTwitterFacebookGoogle+Email
Donor Recruiting & Retention is About to Get Easier
The Pareto principle, aka the 80-20 rule, says that 80% of effects are the result of 20% of causes. In the donor recruiting world, that can be interpreted to mean 80% of donations come from 20% of your donors. You need an aggressive donor loyalty and retention strategy that's always on and always there. Get ready for the future of donor recruiting and retention. Learn more.
Advertisement
 
Science & Health
Silicone "trap" could reduce blood volume needed for tests
Researchers have developed a device that uses a silicone compound to trap a single droplet of liquid, preventing evaporation or contamination. By preserving blood during transportation, the technique could allow single-droplet blood testing, researchers said. The findings were published in the Proceedings of the Royal Society A. ScienceMag.org/ScienceNow blog (4/24)
Share: LinkedInTwitterFacebookGoogle+Email
Microfluidic device extracts cancer cells from blood samples
Researchers from Harvard University and Children's Hospital Boston have developed a device for extracting circulating tumor cells from blood, and the device has potential applications in collecting stem cells. Tests on mice showed the microfluidic device can catch more than 90% of the cancerous cells and keep them intact for culturing, according to findings published in the journal Lab on a Chip. CNET/Cutting Edge blog (4/25)
Share: LinkedInTwitterFacebookGoogle+Email
Autologous cell therapy shows promise in anti-wrinkle trials
Injections of a patient's cultured collagen-producing fibroblast cells improved the appearance of nasolabial fold wrinkles in late-state clinical trials, according to research published in the journal Dermatologic Surgery. The Dermatologist online (4/20)
Share: LinkedInTwitterFacebookGoogle+Email
Emerging Trends
Biopharma is developing almost 300 vaccines
There are almost 300 preventive and therapeutic vaccines under development by biotech firms, according to the Pharmaceutical Research and Manufacturers of America. Vaccines in clinical studies or under FDA review include 170 for infectious diseases and 102 for cancer. PharmaTimes (U.K.) (4/24)
Share: LinkedInTwitterFacebookGoogle+Email
Ultrasound alone may rule out deep vein thrombosis in pregnancy
A study published online in the British Medical Journal showed a single ultrasound test could rule out deep vein thrombosis during and after pregnancy. Researchers followed 210 women who received a complete compression ultrasonography exam. Only two of 177 women who tested negative developed DVT during the follow-up period. Medscape (free registration) (4/24)
Share: LinkedInTwitterFacebookGoogle+Email
 
Industry News & Practice
Small health groups remain slow to adopt EHRs, studies show
A pair of studies in the journal Health Affairs indicated that small, rural hospitals and physician practices continue to lag large, urban facilities in implementing EHRs. The researchers recommended the federal government continue to provide incentives and assistance to smaller practices and step up efforts to help slow adopters deploy EHRs. Modern Healthcare (subscription required) (4/25)
Share: LinkedInTwitterFacebookGoogle+Email
Government & Regulatory
FDA user fee reauthorization faces obstacles
Differences between House and Senate versions of bills reauthorizing the FDA Prescription Drug User Fee Act could delay the bill's progress. Differences include terms for exclusivity periods for new antibiotics, the FDA's mission and guidelines for how the agency determines devices' risks. Politico (4/25)
Share: LinkedInTwitterFacebookGoogle+Email
Association News
Transfusion journal highlights use of platelets to reverse antiplatelet drug effects
An article published in the April issue of Transfusion focuses on the transfusion of platelets to reverse antiplatelet drug effects. The article describes the mechanism of action of new antiplatelet agents and assesses treatment approaches to reverse their action with platelet transfusion or other pharmacologic agents. Continuing medical education credits are being offered for reading and successfully completing a test on the article. Read the abstract or visit the CME website.
Share: LinkedInTwitterFacebookGoogle+Email
Who's Hiring?
Position TitleCompany NameLocation
Country Director - MozambiqueAABBMOZ - Nationwide
Senior Project ManagerBlood Systems, Inc.US - AZ - Scottsdale
Transfusion Safety CoordinatorPacific Diagnostic Laboratories, LLCUS - CA - Santa Barbara
Standards Development SpecialistAABBUS - MD - Bethesda
(CEO), Greater Ozarks RegionAmerican Red CrossUS - AR - Little Rock
Deputy Director, Regulatory Affairs - Cellular TherapyAABBUS - MD - Bethesda
Click here to view more job listings.
 
SmartQuote
One person with a belief is equal to a force of 99 who have only interests."
-- John Stuart Mill,
British philosopher and political economist
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AABB® ->Homepage | Join AABB | Conferences | Marketplace | AABB CareerLink
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tom Parks
Managing Editor:  Amanda Horn
Advertising Manager:  Annette Bacchus
  M: 240.333.6604
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information